Ou Jiang

Dr. Ou Jiang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
RCRan Cui
Ran Cui
ZLZhongxiang Luo
Zhongxiang Luo
XZXialin Zhang
Xialin Zhang
XYXinlin Yu
Xinlin Yu
GYGang Yuan
Gang Yuan
OJOu Jiang
Ou Jiang
Phosphoinositide 3-kinases (PI3Ks), members of the lipid kinase family, play a significant role in modulating immune cell functions, including activation, proliferation, and differentiation. Recent studies have identified the PI3K signaling pathway as a key regulator in tumor biology and the immune microenvironment. This pathway enhances the activity of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), contributing to an immunosuppressive tumor microenvironment that impairs the effectiveness of cancer vaccines and immunotherapies. The present study explores PI3K isoforms, particularly p110γ and p110δ, and their associated signaling pathways. The therapeutic potential of selective PI3K inhibitors and their capacity to act synergistically with immunization strategies are analyzed. Targeting the PI3K signaling pathway represents a promising approach to counteract tumor-induced immune suppression and improve the efficacy of immune checkpoint inhibitors and vaccines, ultimately leading to better clinical outcomes.

28 August 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
QGQiang Geng
Qiang Geng
QYQing Yang
Qing Yang
SCShubei Chen
Shubei Chen
WQWei Qiu
Wei Qiu
XLXiaoling Liu
Xiaoling Liu
OJOu Jiang
Ou Jiang
With the rapid advancement of digestive endoscopy techniques, an increasing number of early gastric cancers (EGCs) have been diagnosed and treated, substantially improving the 5-year survival rate of patients with EGC. Multifocal gastric cancer is a relatively uncommon subtype, and repeated occurrences of multifocal gastric cancer are even less frequently observed. The pathogenesis may involve persistent field cancerization of the background gastric mucosa and, in some patients, an inherited predisposition; evaluation of mismatch repair (MMR) status is an important component of the assessment. Here, we report a young male patient who experienced two episodes of multifocal early gastric cancer over a 9-year period. Both episodes were treated with curative intent—initially by proximal one-third gastrectomy for synchronous multifocal early gastric cancer and subsequently by minimally invasive endoscopic resection for metachronous multifocal early gastric cancer in the remnant stomach. This case suggests that patients with synchronous multifocal early gastric cancer remain at risk for metachronous multifocal gastric cancer even after curative treatment. In particular, among those with high-risk profiles—including a family history of cancer, Helicobacter pylori infection, and gastric mucosal atrophy with intestinal metaplasia—greater emphasis should be placed on high-quality endoscopic screening, long-term surveillance, and genetic susceptibility assessment when indicated.